Haber M - Search Results

1

MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma.

Ferrucci F, Ciaccio R, Monticelli S, Pigini P, di Giacomo S, Purgato S, Erriquez D, Bernardoni R, Norris M, Haber M, Milazzo G, Perini G. Ferrucci F, et al. Among authors: haber m. Biochim Biophys Acta Gene Regul Mech. 2018 Mar;1861(3):235-245. doi: 10.1016/j.bbagrm.2018.01.007. Epub 2018 Feb 3. Biochim Biophys Acta Gene Regul Mech. 2018. PMID: 29408445

2

Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T-cell leukemia xenograft, LALW-2.

Norris MD, Haber M, Kavallaris M, Brian MJ, Lutze LH, White L, Stewart BW. Norris MD, et al. Among authors: haber m. Cancer. 1991 Sep 1;68(5):981-7. doi: 10.1002/1097-0142(19910901)68:5<981::aid-cncr2820680512>3.0.co;2-w. Cancer. 1991. PMID: 1913492

3

Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression.

Norris MD, Haber M, King M, Davey RA. Norris MD, et al. Among authors: haber m. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1435-41. doi: 10.1016/0006-291x(89)92764-2. Biochem Biophys Res Commun. 1989. PMID: 2575383

4

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW. Haber M, et al. J Natl Cancer Inst. 1989 Aug 16;81(16):1250-4. doi: 10.1093/jnci/81.16.1250. J Natl Cancer Inst. 1989. PMID: 2754745

5

Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers.

Norris MD, Kwan E, Haber M, Marshall GM. Norris MD, et al. Among authors: haber m. Leukemia. 1995 Oct;9(10):1779-82. Leukemia. 1995. PMID: 7564525

6

An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro.

Haber M, Norris MD, Kavallaris M, Camacho M, Madafiglio J, Baker CJ, White L, Stewart BW. Haber M, et al. Cancer Lett. 1995 Oct 20;97(1):49-55. doi: 10.1016/0304-3835(95)03950-2. Cancer Lett. 1995. PMID: 7585477

7

Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.

Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M, Norris MD. Marshall GM, et al. Among authors: haber m. Oncogene. 1995 Aug 3;11(3):485-91. Oncogene. 1995. PMID: 7630632

8

Analysis of a novel cDNA encoding a C219-reactive peptide isolated from methotrexate-selected multidrug-resistant human leukemic cells.

Norris MD, Gilbert J, Madafiglio J, Haber M. Norris MD, et al. Among authors: haber m. Gene. 1995 Apr 24;156(2):313-4. doi: 10.1016/0378-1119(94)00541-y. Gene. 1995. PMID: 7758977

9

Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.

Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD. Bordow SB, et al. Among authors: haber m. Cancer Res. 1994 Oct 1;54(19):5036-40. Cancer Res. 1994. PMID: 7923112

10

Expression of retinoic acid-responsive genes in primary neuroblastomas.

Haber M, Madafiglio J, Bordow SB, Gilbert J, Cheung B, Marshall GM, Norris MD. Haber M, et al. Prog Clin Biol Res. 1994;385:245-51. Prog Clin Biol Res. 1994. PMID: 7972216 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

702 results

Search Page

Filters